ANSTO Publications Online >
Journal Publications >
Journal Articles >

Please use this identifier to cite or link to this item: http://apo.ansto.gov.au/dspace/handle/10238/9290

Title: Optimisation of [11C]raclopride production using a synthra GPextent system
Authors: Perkins, G
Sheth, R
Greguric, I
Pascali, G
Keywords: Dopamine
Receptors
Clinical trials
Testing
Synthesis
Impurities
Issue Date: 1-Dec-2014
Publisher: Bentham Science Publishers
Citation: Perkins, G., Sheth, R., Greguric, I., & Pascali, G. (2014). Optimisation of [11C] raclopride production using a synthra gpextent system. Current radiopharmaceuticals, 7(2), 100-106. doi:10.2174/1874471007666141021111635
Abstract: The dopamine D2 receptor radiotracer [(11)C]Raclopride is used extensively in clinical and preclinical imaging. Currently, a wide range of methods to produce [(11)C]Raclopride have been developed using traditional vessel reactions as well as cartridge or captive solvent. This work reports the optimisation of the production of [(11)C]Raclopride using a Synthra GPextent, comparing various methods. With optimised conditions, we were able to obtain 4±2% (ndc) yield of [(11)C]Raclopride (100 GBq [(11)C]CO2, n = 42) in 25 min. The radiochemical purity was >95% with specific activities of 135±41 MBq/nmol at end of synthesis. © 2014 Bentham Science Publishers
URI: https://doi.org/10.2174/1874471007666141021111635
http://apo.ansto.gov.au/dspace/handle/10238/9290
ISSN: 1874-4710
Appears in Collections:Journal Articles

Files in This Item:

There are no files associated with this item.

Items in APO are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback